Sequence analysis of mutations and translocations across breast cancer subtypes
Shantanu Banerji, Kristian Cibulskis, Claudia Rangel-Escareno, Kristin K Brown, Scott L Carter, Abbie M Frederick, Michael S Lawrence, Andrey Y Sivachenko, Carrie Sougnez, Lihua Zou, Maria L Cortes, Juan C Fernandez-Lopez, Shouyong Peng, Kristin G Ardlie, Daniel Auclair, Veronica Bautista-Pina, Fujiko Duke, Joshua Francis, Joonil Jung, Antonio Maffuz-Aziz Show all
Nature | NATURE RESEARCH | Published : 2012
Awarded by NIH
Awarded by Dana-Farber/Harvard SPORE in breast cancer under NCI grant
Awarded by NATIONAL CANCER INSTITUTE
Awarded by NATIONAL HUMAN GENOME RESEARCH INSTITUTE
We would like to thank all patients who contributed samples to this study. This study was a collaboration of the Broad Institute in Cambridge, Massachusetts, USA, and the National Institute of Genomic Medicine (INMEGEN) in Mexico City, Mexico. The work was conducted as part of the Slim Initiative for Genomic Medicine, a project funded by the Carlos Slim Health Institute in Mexico. This work is part of a global effort in collaboration with the International Cancer Genome Consortium (ICGC). The authors would also like to acknowledge J. Barretina and H. Greulich for their critical review of the manuscript. In addition, we would like to acknowledge the technical expertise and data generation efforts of The Broad Institute Biological Samples, Genome Sequencing, and Genetic Analysis Platforms. S. B. has received fellowship support co-sponsored by CancerCare Manitoba and the University of Manitoba. K. K. B. is a recipient of the John Gavin Post-doctoral Fellowship, Genesis Oncology Trust of New Zealand. R. R.-V. and S. L. R.-C. received a scholarship from the Mexican Council of Science and Technology (CONACyT). R. B. is a V Foundation Scholar. A. T. is funded by NIH grant CA122099. This work was partially supported by the Dana-Farber/Harvard SPORE in breast cancer under NCI grant reference CA089393.